aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director SCHIMMEL PAUL
aTyr Pharma | 8-K: Current report
aTyr Pharma | UPLOAD: Others
aTyr Pharma | CORRESP: CORRESP
aTyr Pharma | UPLOAD: Others
4: Statement of changes in beneficial ownership of securities-Officer DENYES NANCY
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director COUGHLIN TIMOTHY
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Broadfoot Jill Marie
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sanjay
aTyr Pharma | 8-K: Current report
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director CLARKE JOHN K
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Gross Jane A
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Lucas Svetlana
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director SCHIMMEL PAUL
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Zaknoen Sara
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director COUGHLIN TIMOTHY
aTyr Pharma | 10-Q: Quarterly report
aTyr Pharma | 8-K: aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma | DEFA14A: Others
aTyr Pharma | ARS: Annual Report to Security Holders
No Data